Medicina
Departamento
Washington University in St. Louis School of Medicine
San Luis, Estados UnidosPublicaciones en colaboración con investigadores/as de Washington University in St. Louis School of Medicine (58)
2024
-
Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study
Journal of Thoracic Oncology, Vol. 19, Núm. 2, pp. 285-296
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1–High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial
Journal of Thoracic Oncology, Vol. 18, Núm. 12, pp. 1731-1742
-
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer
Breast, Vol. 67, pp. 94-101
-
Gaps in clinical research in frontotemporal dementia: A call for diversity and disparities–focused research
Alzheimer's and Dementia, Vol. 19, Núm. 12, pp. 5817-5836
-
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial
Annals of Oncology, Vol. 34, Núm. 10, pp. 885-898
-
Risk Factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant Recipients: A Multinational Case-Control Study
Clinical Infectious Diseases, Vol. 76, Núm. 3, pp. E995-E1003
-
Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 2893-2903
2022
-
Breaks in peristaltic integrity predict abnormal esophageal bolus clearance better than contraction vigor or residual pressure at the esophagogastric junction
Neurogastroenterology and Motility, Vol. 34, Núm. 2
-
Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial
The Lancet Haematology, Vol. 9, Núm. 1, pp. e14-e25
-
High-Resolution Manometry Thresholds and Motor Patterns Among Asymptomatic Individuals
Clinical Gastroenterology and Hepatology, Vol. 20, Núm. 3, pp. e398-e406
-
Long-term Outcomes With Ibrutinib Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis of 3 Clinical Trials With Nearly 10 Years of Follow-up
HemaSphere
-
Long-term disease control and safety with the anti-CCR4 antibody mogamulizumab: Post-hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T-cell lymphoma
Dermatologic Therapy
-
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation
The oncologist, Vol. 27, Núm. 7, pp. e561-e570
-
Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial
European Journal of Cancer, Vol. 160, pp. 61-71
-
Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial
Journal for immunotherapy of cancer, Vol. 10, Núm. 8
-
Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics
Blood Advances, Vol. 6, Núm. 3, pp. 920-930
2021
-
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
The Lancet Oncology, Vol. 22, Núm. 5, pp. 643-654
-
Esophagogastric junction morphology and contractile integral on high-resolution manometry in asymptomatic healthy volunteers: An international multicenter study
Neurogastroenterology and Motility, Vol. 33, Núm. 6
-
Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM
The Lancet Infectious Diseases, Vol. 21, Núm. 12, pp. e375-e386